Galileo Life Sciences, Inc. Reports Termination of Option Agreement With Easton Pharmaceuticals

Galileo Life Sciences, Inc. (‘the Company”) (OTC PINK: MDRM) formerly known as Modern Mobility Aids Inc. announced today that as a result of several breaches of agreement, it has terminated its option agreement with Easton Pharmaceuticals of Toronto. Contrary to press releases on June 1, 2015 and June 17, 2015 by Easton... more →
Posted in: Press

Galileo Life Sciences Reports Significant Progress

Galileo Life Sciences, Inc. (“the Company”) (OTC PINK: MDRM), formerly Modern Mobility Aids Inc., announced today that it is nearing its goal of becoming a licensed Canadian producer and distributor of high quality medical marijuana under Health Canada’s Marihuana Medical Purposes Regulations (“MMPR”). Galileo... more →
Posted in: Press

Galileo Life Sciences, Inc. Announces Board and Management Changes

Galileo Life Sciences (“the Company”) (PINKSHEETS:MDRM) announced that it has strengthened its Board of Directors with the appointment of three new members and accepted the resignation of Kenneth Pinckard as CEO and member of the Board of Directors. The three new Directors include: Dr. Baseer Khan, an internationally... more →
Posted in: Press

Modern Mobility Aids, Inc. Announces Name Change

Modern Mobility Aids, Inc. (“the Company”) (OTC Pink: DRM) announced today that the Board of Directors and shareholders approved the Company’s name change to Galileo Life Sciences, Inc. “We are very pleased to adopt the name Galileo Life Sciences. We believe it better reflects our objective to nurture innovative... more →
Posted in: Press